| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/27/1993 | CA2083360A1 Tri-arginine insulins |
| 05/26/1993 | EP0543713A1 Ethanolamine benzoate derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/26/1993 | EP0543662A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 05/26/1993 | EP0543417A1 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/26/1993 | EP0543310A2 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same |
| 05/26/1993 | EP0543076A2 Wheat alpha-amylase inhibitor for the treatment of diabetes |
| 05/26/1993 | EP0543018A1 Antidiabetic agent |
| 05/26/1993 | EP0543001A1 Use of antiarrhythmic agents to lower cholesterol |
| 05/26/1993 | EP0542979A1 Therapeutic composition for sustained release of magnesium |
| 05/26/1993 | EP0542864A1 Treatment for hypercholesterolemia. |
| 05/26/1993 | EP0542816A1 Oxazolidine dione derivatives |
| 05/26/1993 | EP0527802A4 Ligand for the neu gene product |
| 05/25/1993 | US5214206 Anticholesterol agents, inhibitors of acylcoenzyme A |
| 05/25/1993 | US5214202 Method for preparing benzoic acid derivatives |
| 05/25/1993 | CA1318169C Food compositions with superior blood cholesterol lowering properties |
| 05/21/1993 | CA2083323A1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses |
| 05/20/1993 | WO1993010147A1 Novel amylin antagonist peptides and uses therefor |
| 05/20/1993 | CA2100743A1 Amylin antagonist peptides and uses therefor |
| 05/19/1993 | EP0542398A1 Rice extract useful as active oxygen scavenger |
| 05/19/1993 | EP0541524A1 Food and feedstuff. |
| 05/19/1993 | EP0408713B1 Phenylsulphone derivatives |
| 05/19/1993 | EP0407410B1 Antidiabetic 3-halo-beta-aminoestranes |
| 05/19/1993 | CN1072173A Therapeutic agents |
| 05/18/1993 | US5211950 Stabilized calcitonin pharmaceutical composition |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009115A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors |
| 05/13/1993 | WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 05/13/1993 | WO1993009101A1 Mercapto-amide derivatives as inhibitors of the neutral endopeptidase |
| 05/13/1993 | WO1993009093A1 Vitamin d amide derivatives |
| 05/13/1993 | WO1993008687A1 Alteration of rate and character of hair growth |
| 05/13/1993 | WO1993005751A3 Osteogenic proteins in the treatment of bone deseases |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2118688A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 05/12/1993 | EP0540857A1 Process for preparing stable, complexe emulsion compositions of the water-oil-water type and use of said compositions as cosmetic preparations |
| 05/12/1993 | EP0398945B1 New topical preparation for treatment of alopecia |
| 05/12/1993 | CN1071922A Benzanilide derivatives |
| 05/12/1993 | CN1020609C Process for preparing castanospermine esters |
| 05/11/1993 | CA1317593C Method of ameliorating epileptic seizures |
| 05/11/1993 | CA1317546C Pharmaceutical preparations containing mixtures of hydroxy derivatives of vitamin d |
| 05/11/1993 | CA1317545C Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/05/1993 | EP0540462A1 L-Glutamine or a peptide rich in L-glutamine for the manufacture of an oral formulation for the treatment of a fall in blood L-glutamine levels |
| 05/05/1993 | EP0539491A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 05/05/1993 | CA2081808A1 Combination of calcium antagonists with cholinesterase inhibitors |
| 05/04/1993 | US5208041 Essentially pure human parathyroid hormone |
| 05/04/1993 | CA1317222C Increasing endogenous growth hormone |
| 05/01/1993 | CA2081674A1 Heterocyclic compounds |
| 04/29/1993 | WO1993008184A1 Hiv protease inhibitors |
| 04/29/1993 | WO1993008173A1 Quinoxaline derivates with affinity for quisqualate-receptors |
| 04/29/1993 | WO1993008171A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | WO1993008170A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | WO1993008169A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | WO1993008155A1 Lignan analog, production thereof, and hypolipidemic drug |
| 04/29/1993 | WO1993007871A1 Methods for the treatment of hyperlipidemia using azaspiranes |
| 04/29/1993 | WO1993007869A1 Methods for treatment of hyperlipidemia using azaspiranes |
| 04/29/1993 | WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy |
| 04/29/1993 | CA2121816A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | CA2121815A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | CA2121814A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | CA2099270A1 Quinoxaline derivatives with affinity for quisqualate-receptors |
| 04/28/1993 | EP0539192A1 HIV Protease inhibitors |
| 04/28/1993 | EP0539066A1 Heterocyclic compounds useful as angiotensin II antagonists |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206269 Highly concentrated amino acid solution |
| 04/27/1993 | US5206253 Disphosphonic acid derivatives, processes for their production and pharmaceutical preparations containing these compounds |
| 04/27/1993 | US5206247 Spiro(4.5.)decane compounds |
| 04/27/1993 | US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | CA1317069C2 Synthetic peptides having pituitary growth hormone releasing activity |
| 04/27/1993 | CA1316933C Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 04/27/1993 | CA1316927C Antihypercholesterolemic beta-lactones |
| 04/24/1993 | CA2081134A1 Hiv protease inhibitors |
| 04/21/1993 | EP0538192A1 New 17-beta-substituted aza-androstanderivatives |
| 04/21/1993 | EP0538080A1 4-Aminomethylpiperidine derivatives, process for their preparation and their use in therapy |
| 04/21/1993 | EP0538000A1 Indole and indazole carbamates as leukotriene antagonists |
| 04/21/1993 | EP0537949A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran |
| 04/21/1993 | EP0537139A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced. |
| 04/20/1993 | US5204364 N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds |
| 04/20/1993 | US5204351 Antiarteriosclerosis, anticholesterol agents |
| 04/20/1993 | US5204350 Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| 04/20/1993 | US5204346 Pyrazolopyridine compounds |
| 04/20/1993 | US5204340 Tetrahydrobenz(c,d)indole serotonin agonists |
| 04/20/1993 | US5204334 Inhibition of calcium resorption; osteoporosis; Paget's disease; bone disorders |
| 04/20/1993 | US5204115 Granules with a non-cariogenic binder |
| 04/18/1993 | CA2080405A1 Indole carbamates as leukotriene antagonists |
| 04/15/1993 | WO1993007177A1 Method of producing starch decomposition products with a narrow molecular-weight distribution |
| 04/15/1993 | WO1993007167A1 Cholesterol lowering compounds and process for making them |
| 04/15/1993 | WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/15/1993 | WO1993006845A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27¿ AND USE IN OSTEOPOROSIS TREATMENT |
| 04/15/1993 | WO1993006839A1 Method for enhancing gut absorption |
| 04/15/1993 | WO1993006811A2 Vanadium compositions |
| 04/15/1993 | CA2120946A1 Parathyroid hormone analogues substituted at aa 25.26.27 and use in osteoporosis treatment |
| 04/15/1993 | CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/15/1993 | CA2120338A1 Vanadium compositions |
| 04/15/1993 | CA2119656A1 Method of producing starch decomposition products with a narrow molecular-weight distribution |
| 04/15/1993 | CA2079414A1 Heterocyclic compounds |
| 04/14/1993 | EP0536316A1 Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof |
| 04/14/1993 | EP0536269A1 The use of inositoltrisphosphate for the preparing of medicaments |